Navigation Links
,,Ibuprofen to lower risk of Parkinson’s diseas

Scientists from Harvard School of Public Health have reported that over the counter anti-inflammatory drugs// like ibuprofen are beneficial as they can lower the risk of Parkinson’s disease.

The study had tracked participants who took daily one ibuprofen tablet, men and women, for over the period of 8.5 yrs. These people seemed to have a 38% less chance of having Parkinson’s disease than the people who did not take the drug.

There were no such association found between Parkinson’s and other drugs like aspirin or any other non-steroidal anti-inflammatory drugs.

The study suggests that one of the reasons of Parkinson’s disease may be neuro-inflammation of the brain cells and hence non-aspirin based anti-inflammatory drugs may be successful in lowering the incidence of the disease. But scientists are yet to explain why the result is so strong for the case of ibuprofen only. Researchers are of the opinion that this is one area that needs to be studied in detail before ibuprofen can be prescribed as a preventive measure.

The study was presented in the American Academy of Neurology 57th Annual Meeting this year.
'"/>




Page: 1

Related medicine news :

1. Spouses and other partners lower blood pressure says new research
2. Brisk Walking lowers memory loss in women
3. B Vitamin protects and lowers toxicity of Arthritis Drug
4. Tea drinkers have lower rates of heart disease
5. Estrogen lowers cancer risk
6. Lecithin lowers cholesterol absorption in body
7. Salt reduction lowers blood pressure
8. Exercise lowers Risk of Ovarian Cancer
9. Cholesterol lowering drugs increase neuropathy risk
10. Hypertension drugs could lower Disability
11. Fish rich diet lowers leptin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching ... innovative Unified Instance Manager architecture, meeting the needs of multichannel growth and ... the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to announce that ... for Texas, they are expanding their presence in Dallas. One of the most exciting ... bring new jobs to the Dallas and Forth Worth market. STAT takes pride in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Healthcare is ... Dr. Botelho advocates for the mass media launching of story movements to highlight ... to share their unfortunate experiences; such a movement can generate the network power ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016 Australia Glaucoma Surgery ... GlobalData,s new report, "Australia Glaucoma Surgery Devices Market ... the Australia Glaucoma Surgery Devices market. The report ... (in units) and average prices (USD) within market ... also provides company shares and distribution shares data ...
(Date:12/8/2016)... KEY FINDINGS The global medical lifting sling ... for growth of the medical lifting sling market are ... high recovery cost of injuries and government initiatives to ... refers to an assistive device that helps caregiver transfer ... the lift and hold the patient. It is important ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology: